ABK Biomedical, Inc. Secures US$35 Million Series D Financing

ABK Biomedical, Inc. closes oversubscribed Series D financing round, focusing on ongoing clinical operations and commercialization preparation.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here